4//SEC Filing
Lehrer-Graiwer Joshua 4
Accession 0000899243-20-007676
CIK 0001629137other
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 7:37 PM ET
Size
11.0 KB
Accession
0000899243-20-007676
Insider Transaction Report
Form 4
Lehrer-Graiwer Joshua
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-03-05$65.30/sh−1,138$74,311→ 2,595 total - Sale
Common Stock
2020-03-09$59.90/sh−938$56,186→ 2,595 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-03-09−938→ 1,875 totalExercise: $19.89Exp: 2026-09-07→ Common Stock (938 underlying) - Exercise/Conversion
Common Stock
2020-03-09$19.89/sh+938$18,657→ 3,533 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]Represents the weighted average sale price of the shares sold ranging from $59.80 to $60.00 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares of Common Stock underlying the option shall vest in 16 equal quarterly installments over 4 years from September 8, 2016, so long as the Reporting Person continues as an employee or other service provider of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the Issuer.
Documents
Issuer
Global Blood Therapeutics, Inc.
CIK 0001629137
Entity typeother
Related Parties
1- filerCIK 0001789673
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 8:00 PM ET
- Accepted
- Mar 9, 7:37 PM ET
- Size
- 11.0 KB